Request Deal Involvement
Novo Holdings led a $125m Series C funding round in Hummingbird Bioscience.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Latham & Watkins
legal advisors
Latham & Watkins
or
Principals
bidder
FRAZIER HEALTHCARE PARTNERS
bidder
OCTAGON CAPITAL
bidder
HERITAS CAPITAL
bidder
PUREOS BIOVENTURES
bidder
AMGEN INC
bidder
DROIA VENTURES
bidder
POLARIS PARTNERS
bidder
SK GROUP
bidder
EDBI
bidder
ALTIUM CAPITAL
target
HUMMINGBIRD BIOSCIENCE
bidder
MORNINGSIDE VENTURE CAPITAL
bidder
AFFINITY ASSET ADVISORS
bidder
ALLY BRIDGE GROUP
bidder
MIRAE ASSET CAPITAL CO LTD
bidder
NOVO HOLDINGS A/S
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite